13 results
rheumatology differential lupus management erythematosus table treatment activetb ana antinuclear classification comparison druginduced latenttb tb tuberculosis vasculitis acidosis algorithm antibodies
Antinuclear Antibodies (ANA) ANA or Anti-NucIear Antibody refers to antibodies against antigens in the nucleus → like
likely it will be clinically ... disease (MCTD), Drug-induced ... Non-Rheumatic Diseases: Malignancy ... Biliary Cirrhosis, Drug-Induced ... #rheumatology #diagnosis
Differential Diagnosis of Hypoglycemia Evaluation of Hypoglycemia Patients with known diabetes who are not systemically ill and can
of Hypoglycemia Evaluation ... #EM #IM #Hypoglycemia ... Differential #Algorithm #Drugs ... #Malignancy #Exogenous ... #Hypoglycemic #Ddxof
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
vs SLE Drug Induced ... to 1:1 F:M • Clinical ... months to years) Systemic ... 40, F:M 9:1 • Clinical ... #rheumatology #diagnosis
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Systemic Lupus Erythematosus ... (SLE) - Diagnosis ... 40, F:M 9:1 • Clinical ... Workup: - ANA ... • Evolution:
Antinuclear antibodies and Systemic lupus Anti-dsDNA 60-80% Association with disease activity (when with Farr assay) and lupus nephritis. Can
antibodies and Systemic ... (60-70%) & drug-induced ... is clinically suspected ... autoantibodies #Systemic ... erythematosus #diagnosis
SLE (Systemic Lupus Erythematosus) Suspect: Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
SLE (Systemic Lupus ... ) Suspect: Clinical ... Differential Diagnosis ... extremities Drug ... • Antihistone: Drug
Differentiating NBTE from Infective Endocarditis No pathognomonic signs/symptoms or echo features that are specific to NBTE, and
conditions: Autoimmune (SLE ... /APLS), Malignancy ... features: Fever -, Systemic ... of intravenous drug ... features: Fever +, Systemic
Vasculitis and Vasculitides - Differential Diagnosis Framework When to Consider Vasculitis: • Purpura, ischemic skin lesions •
- Differential Diagnosis ... < 30 years - Aorta ... branches • GCA: - Aorta ... LFT • ESR • ANA ... vasculitis, and SLE
Vasculitis - Differential Diagnosis Framework When to Consider Vasculitis: • Purpura, ischemic skin lesions • Mononeuritis multiplex • Hematuria, proteinuria,
diseases, such as SLE ... atherosclerotic disease, drug ... < 30 years • Aorta ... Arteritis): • Aorta ... exposure or Dx of malignancy
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... tracheobronchial stenosis, malignancy ... Tuberculosis Diagnosis ... Tuberculosis #TB #Diagnosis
No results found for "ddxof evaluation aorta aaa em malignancy clinical drugs sle diagnosis systemic"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #ddxof #evaluation #aorta #aaa #em #malignancy #clinical #drugs #sle #diagnosis #systemic